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Abstract
Aims—To estimate differences in post-treatment psychosocial functioning among treatment 
“failures” (i.e., heavy drinkers, defined as 4+/5+ drinks for women/men) from two large multi-site 
clinical trials, and to compare these levels of functioning to those of the purported treatment 
“successes” (i.e., non-heavy drinkers).
Design—Separate latent profile analyses of data from COMBINE and Project MATCH, 
comparing psychosocial outcomes across derived classes of heterogeneous treatment responders.
Setting—Eleven U.S. academic sites in COMBINE, 27 U.S. treatment sites local to nine research 
sites in Project MATCH.
Participants—962 individuals in COMBINE (69% male, 77% white, mean age: 44 years) 
treated January 2001 to January 2004 and 1,528 individuals in Project MATCH (75% male, 80% 
white, mean age: 40 years) treated April 1991 to September 1994.
Measurements—In COMBINE, we analyzed health, quality of life, mental health symptoms, 
and alcohol consequences 12-months post-baseline. In Project MATCH, we examined social 
functioning, mental health symptoms, and alcohol consequences 15-months post-baseline.
Findings—Latent profile analysis of measures of functioning in both samples supported a three-
profile solution for the group of treatment “failures,” characterized by high-functioning, average-
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functioning, and low-functioning individuals. The high-functioning treatment “failures” were 
generally performing better across measures of psychosocial functioning at follow-up than 
participants designated treatment “successes” by virtue of being abstainers or light drinkers.
Conclusions—Current Food and Drug Administration guidance to use heavy drinking as 
indicative of treatment “failure” fails to take into account substantial psychosocial improvements 
made by individuals who continue to occasionally drink heavily post-treatment.
Introduction
Historically, success in alcohol use disorder (AUD) treatment has been defined by 
abstinence from alcohol. In more recent decades, researchers have advocated for the use of 
“low-risk drinking” as a successful endpoint in alcohol treatment (1). Both the U.S. Food 
and Drug Administration (FDA) and the European Medicines Agency (EMA) have adopted 
low-risk drinking as endpoints for pharmaceutical trials (2–4). Currently, the FDA low risk 
drinking endpoint is defined as no heavy drinking days, with a heavy drinking day defined as 
consuming 4 or more drinks for a woman, and 5 or more drinks for a man. The 4+/5+ cutoff 
to distinguish between treatment success and treatment failure is widely used in the field 
(Maisto et al., in press).
This 4+/5+ heavy drinking definition originated from research on “binge drinking” among 
college students (5) and critiques of the 4+/5+ “binge” or “heavy” drinking definition can be 
levied against the very data that led to its widespread adoption (6). First, this same research 
found a linear relationship between consumption level and the experience of consequences, 
suggesting the 4+/5+ cutoff was arbitrary. Second, the research focused on college students, 
thus researchers should correctly be cautious toward applying these principles to clinical 
populations where “in the context of full-blown alcoholic drinking…five drinks seem 
comparatively small” (7) (p. 287). Third, reporting that individuals above the cutoff 
experience more consequences than individuals below the cutoff (5,8,9) is a very weak 
validity test.
Given the weak validity of any current approach that uses a binary cutoff for consumption as 
an indicator of success or failure, it makes sense to look directly at the outcome for which 
consumption currently stands as a proxy: psychosocial functioning. Though areas of life-
functioning post-treatment have received some attention as potential outcomes in the 
literature (10–12); the complexity surrounding what “functioning” is, compared to the 
simplicity of tallying the number of drinks per day or percentage of days that an individual 
drinks, has inhibited investigation of treatment effects along these admittedly blurrier lines. 
However, given that the current edition of the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-5) (13), and all preceding versions of the DSM include no mention of 
consumption level in the criteria that lead to a diagnosis of AUD, an investigation of 
outcomes based on psychosocial variables deserves merit.
Purpose
As currently supported by the FDA, individuals who report any heavy drinking, defined as 
4+/5+ drinks per occasion for women/men during a follow-up period, are considered 
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treatment failures. The use of the “any heavy drinking” endpoint as a surrogate measure of 
clinical benefit, per recommendations by the FDA (3), is based on unpublished data which 
showed that drinking above these limits was associated with significantly greater 
consequences and worse psychosocial functioning. The FDA guidance assumes that all 
individuals engaged in any heavy drinking will show significant consequences and 
impairment in functioning. However, to date, no research has examined this assumption. 
Using data from two of the largest alcohol clinical trials conducted in the United States 
(U.S.), COMBINE (14) and Project MATCH (15), we used latent profile analysis (LPA) to 
examine potential heterogeneity among heavy drinkers in terms of psychosocial functioning, 
and compare their post-treatment functioning to those deemed treatment “successes” (i.e., 
light drinkers and abstainers). LPA is a person-centered statistical approach that can be used 
to identify distinct subpopulations based on various indicator variables. In our secondary 
data analysis, we use several measures of psychosocial functioning as indicators in an 
attempt to identify distinct groups of individuals who differ in psychosocial functioning at 
follow-up (i.e., 12- and 15-months post-baseline in COMBINE and Project MATCH, 
respectively). Given previous studies demonstrating heterogeneity of treatment response 
(16–18), we hypothesized those individuals who exceeded heavy drinking limits (i.e., 
treatment “failures”) would be a heterogeneous group defined by subsets of individuals with 
discrete levels of psychosocial functioning.
Method
Participants and Procedure
Data for the present study came from two multisite randomized clinical trials, the 
COMBINE study (19), and Project MATCH (15). The COMBINE study recruited 1,383 
participants from inpatient and outpatient referrals at 11 study sites and in the surrounding 
communities. Participants were randomly assigned to conditions consisting of some 
combination of pharmacotherapy, medication management and/or a combined behavioral 
intervention (CBI). Project MATCH recruited 1,726 participants from 27 treatment sites 
local to nine U.S. research sites. The participants were randomly assigned to cognitive 
behavioral therapy, motivational enhancement therapy, or 12-step facilitation.
Measures
Alcohol consumption—In both studies, alcohol consumption was assessed using the 
Form 90 interview (20), which is a calendar-based measure in which participants report the 
number of standard drinks they consumed on each day during the response period (e.g., past 
90 days). We selected individuals into the “failure” subsample if they reported > 0% heavy 
drinking days (defined as consuming 4+/5+ standard drinks per day for women/men) during 
the previous 90 days of the follow-up period (10–12 months post-baseline in COMBINE; 
13–15 months post-baseline in Project MATCH).
Alcohol Consequences—In both studies, alcohol consequences were assessed using the 
Drinker Inventory of Consequences (DrInC) (21). In both studies, we used a total score as a 
global indicator of negative consequences. Reliability and means were similar for 
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COMBINE (M=31.14; SD=21.55; α=.95) and Project MATCH (M=36.77; SD=25.02; α=.
96).
Health—In COMBINE, health was assessed using the 12-item SF-12 (22) measured on a 5-
response scale. We used the mental health (M=−0.47; SD=1.05; α=.86) and physical health 
(M=0.13; SD=0.89; α=.86) scores as indicators of overall health.
Quality of life—In COMBINE, quality of life was assessed using the 25-item World 
Health Organization Quality of Life Scale- Brief Version (WHOQOL-BREF) (23) measured 
on a 5-response scale. We used the physical health (M=28.07; SD=4.39; 7 items; α=.60), 
psychological (M=21.85; SD=3.98; 6 items; α=.76), social relationships (M=10.29; 
SD=2.49; 3 items; α=.71), and environment (M=30.08; SD=5.38; 8 items; α=.82) subscales 
as indicators of overall biopsychosocial functioning.
Mental health symptoms—In COMBINE, mental health symptoms were assessed using 
the 53-item Brief Symptom Inventory (24) measured on a 5-response scale. We used the 
depression (M=58.29; SD=11.13; 7 items; α=.90), anxiety (M=53.61; SD=11.19; 6 items; 
α=.85), hostility (M=52.13; SD=9.90; 5 items; α=.80) and interpersonal sensitivity 
(M=54.51; SD=10.85; 4 items; α=.86) subscales as indicators of psychological functioning. 
In Project MATCH, mental health symptoms were assessed using the psychiatric severity 
subscale of the 57-item Addiction Severity Index (ASI) (25) measured on a binary yes/no 
response scale (M=0.16; SD=0.21; α=.67), and the 21-item Beck Depression Inventory 
(BDI) measured on a 4-point response scale (M=10.44; SD=9.26; α=.92).
Social functioning—In Project MATCH, social functioning was assessed using the 81-
item Psychosocial Functioning Inventory (26) measured on a 4-response scale. We used the 
social behavior role (M=3.26; SD=0.53; 14 items; α=.85) and overall social performance 
(M=3.70; SD=0.78; 3 items α=.85) subscales as indicators of psychosocial functioning.
Statistical Analysis
Within two independent samples of treatment “failures,” we conducted latent profile 
analyses (LPAs) using Mplus 7.11 (27) to determine the number of distinct heavy drinking 
subpopulations based on their psychosocial functioning 12–15 months post-baseline. As 
recommended by previous research (28,29), we relied on goodness-of-fit indexes, such as 
the Akaike Information Criterion (AIC) (30) and Bayesian Information Criterion (BIC) (31), 
as well as tests of statistical significance to settle upon the number of latent classes. 
Specifically, to determine the number of latent classes across our two analytic samples (i.e., 
COMBINE and Project MATCH), we used the Lo-Mendell-Rubin Adjusted Likelihood 
Ratio Test (32,33), which compares whether a k class solution fits better than a k – 1 class 
solution.
Further, upon settling on a class solution, we then compared the latent classes to each other 
and to a group of abstainers/light drinkers using analysis of variance (ANOVA) with Tukey 
post hoc comparisons. We also tested the equality of means across latent classes on each 
psychosocial variable using pseudo-class-based multiple imputations (34), and found the 
same pattern of results (see Tables S1 and S2).
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Of 1,383 total participants in COMBINE, 962 provided necessary data during the 12-month 
follow-up period (i.e., approximately 10-, 11-, and 12-months post-baseline) for analysis. 
This subsample was not significantly different than the full sample on most baseline 
psychosocial functioning indicators except that the full sample had a slightly higher baseline 
DrInC score [t(1379)=2.50, p=.013, d=.146] and slightly lower baseline depression score 
[t(1379)= −2.01, p=.045, d=.118]. In this subsample, 416 (43.24%) either abstained or drank 
below the heavy drinking threshold and these individuals would be considered treatment 
“successes” according to current FDA guidance. However, 546 (56.76%) would be 
considered treatment “failures” based on reporting heavy drinking (defined as 4+/5+ drinks 
on any occasion for women/men) during the follow-up period. =Latent profile analysis was 
conducted on these 546 subjects who were categorized as heavy drinkers and provided data 
on the psychosocial outcome indicators
COMBINE Latent Profile Analysis
Latent classes were based on the pattern of means of eleven separate psychosocial 
functioning variables from four separate measures (indicators are in parentheses) at 12 
months post-baseline: the SF-12 (physical and mental health), the WHOQOL-BREF 
(physical health, psychological domain, social relationships domain, and environment 
domain), the BSI (depression, anxiety, hostility, and interpersonal sensitivity), and the DrInC 
(total consequences). Higher scores on the SF-12 and WHOQOL-BREF variables indicate 
healthier psychosocial functioning; while lower scores on the BSI and DrInC variables 
indicate healthier psychosocial functioning. As can be expected, all SF-12 and WHOQOL-
BREF psychosocial variables were significantly positively correlated with each other (except 
SF-12 mental and SF-12 physical health), and significantly negatively correlated with all 
BSI and DrInC variables. Further, all BSI and DrInC variables were significantly positively 
correlated with each other. Within the LPA analytic sample (n=546), the Likelihood Ratio 
Test (LRT) suggested that a 3-class solution fit better than a 2-class solution (p=.002) and a 
4-class solution did not fit significantly better than a 3-class solution (p=.208). Although the 
AIC and BIC continue to improve (i.e., decrease) for all class solutions (see Table 1), given 
the LRT, we selected the 3-class solution.
The relative entropy value of .892 indicates that it is estimated that about nine-tenths of 
subjects were correctly classified in the appropriate latent class, which is considered high 
classification quality (i.e., >.80) (35).
Class Comparisons: Comparing “Successes” and “Failures”
Figure 1 depicts the pattern of means across the latent classes, Table 2 summarizes the 
statistical tests of these differences, and Table S3 summarizes the effect sizes of changes 
from baseline to follow-up. Scores have been standardized based on the entire COMBINE 
sample distribution to have a mean of 0 and standard deviation of 1.0, so that positive values 
are above the mean and negative values are below the mean (a value of +1.0=1 standard 
deviation above the mean). Class 1 comprised 18.30% of the sample (N=99.90), and we 
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label this class the “Low Functioning” group as they were extremely low on quality of life 
indicators (i.e., SF-12 and WHOQOL-BREF; −1.53 < zs < −.52), while extremely high on 
mental health/negative consequences indicators (i.e., BSI and DrInC; 1.43 < zs < 1.64). On 
average, their psychosocial functioning worsened from baseline to follow-up (mean d=−.
136). Class 2 comprised 37.56% of the sample (N=205.06), and we label this class the 
“Average Functioning” group as they were close to average on quality of life indicators (−.
54< zs < −.01), and close to average on mental health/negative consequences indicators (.45 
< zs < .62). On average, their psychosocial functioning improved moderately from baseline 
to follow-up (mean d=.271). Finally, the largest group, Class 3, comprised 44.15% of the 
sample (N=241.03), and we label this class the “High Functioning” group as they were 
relatively high on quality of life indicators (.08 < zs < .52), and relatively low on mental 
health/negative consequences indicators (−.60 < zs < −.20). On average, their psychosocial 
functioning improved substantially from baseline to follow-up (mean d=.600). Importantly, 
with the exception being higher on DrInC scores, the “High Functioning Failures” had 
significantly better psychosocial functioning on many indicators (12 Mental Health, 
WHOQUOL-BREF Psychological Domain, BSI Depression, BSI Anxiety, and BSI 
Interpersonal Sensitivity) and were not significantly different on the other indicators (SF-12 
Physical Health, WHOQUOL-BREF Physical Health, Social Relationship Domain, 
Environmental Domain, and BSI Hostility) compared to “Successes”.
Project MATCH Sample
Of 1,726 total participants in Project MATCH, 1,528 provided necessary data during the 15-
month follow-up period (i.e., approximately 13-, 14-, and 15-months post-baseline) for 
analysis. This subsample was not significantly different than the full sample on all baseline 
psychosocial functioning indicators except that the full sample had a slightly higher baseline 
psychiatric severity score [t(1712)=1.987, p=.047, d=.169]. In this subsample, 716 (46.86%) 
either abstained or drank below the heavy drinking threshold (treatment “successes”) and 
812 (53.14%) would be considered treatment “failures” based on reporting heavy drinking 
during the follow-up period. Latent profile analysis was conducted on these 812 subjects 
who were categorized as heavy drinkers and provided data on the psychosocial outcome 
indicators.
Project MATCH Latent Profile Analysis
Latent classes were based on the pattern of means of five separate psychosocial functioning 
variables from four separate measures (indicators are in parentheses) at 15 months post-
baseline: the DrInC (total consequences), the ASI (psychiatric severity), the BDI 
(depression), and the PFI (social role behavior and overall social role performance). Lower 
scores on the DrInC, ASI, and BDI variables indicate healthier psychosocial functioning, 
while higher scores on the PFI variables indicate healthier psychosocial functioning. As can 
be expected, the DrInC, ASI, and BDI psychosocial variables were significantly positively 
correlated with each other, and significantly negatively correlated with both PFI variables. 
Within the LPA analytic sample (n=812), the LRT suggested that a 3-class solution fit better 
than a 2-class solution (p=.048) and a 4-class solution did not fit significantly better than a 
3-class solution (p=.109). Although the AIC and BIC continue to improve (i.e., decrease) for 
all class solutions (see Table 1), given the LRT, we selected the 3-class solution. The relative 
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entropy value of .821 indicates that it is estimated that about five in six subjects were 
correctly classified in the appropriate latent class.
Class Comparisons: Comparing “Successes” and “Failures”
Figure 2 depicts the pattern of means across the latent classes, Table 3 summarizes the 
statistical tests of these differences, and Table S4 summarizes the effect sizes of changes 
from baseline to follow-up. Again, scores were standardized based on the entire Project 
MATCH sample so that positive values are above the mean and negative values are below 
the mean. Class 1 comprised 11.50% of the sample (N=93.36), and we label this class the 
“Low Functioning” group as they were extremely high on the mental health/negative 
consequences indicators (i.e., DrInC, ASI, and BDI; 1.37 < zs < 2.40), and extremely low on 
the social functioning indicators (i.e., PFI; zs=−1.77). On average, their psychosocial 
functioning worsened from baseline to follow-up (mean d=−.404). Class 2 comprised 
35.28% of the sample (N=286.46), and we label this class the “Average Functioning” group 
as they were closer to average on mental health/negative consequences indicators (.46 < zs 
< .75) and social functioning indicators (−.79 < zs < −.74). On average, their psychosocial 
functioning improved modestly from baseline to follow-up (mean d=.126). Finally, the 
largest group, Class 3, comprised 53.22% of the sample (N=432.18), and we label this class 
the “High Functioning” group as they were relatively low on all mental health/negative 
consequences indicators (−.43 < zs < −.36), and higher than average on the social 
functioning indicators (.34 < zs < .40). On average, their psychosocial functioning improved 
substantially from baseline to follow-up (mean d=.604). The “High Functioning Failures” 
were functioning at levels that were similar to (PFI Overall Social Role Performance) or 
significantly better than the “Successes” on almost all indicators (ASI Psychiatric Severity, 
BDI Depression, and PFI Social Behavior Role), with the only exception being the scores on 
the DrInC.
Supplementary Analyses
We conducted additional LPA analyses in the full sample in COMBINE and Project 
MATCH and then distinguished the classes using the binary indicator of “success” versus 
“failure.” Consistent with the results described above (see Tables S5–S7 and Figures S1–
S2), these results demonstrate considerable overlap between “successes” and “failures” in 
psychosocial functioning. In both samples, about 40% of the individuals in the high 
functioning group were considered treatment failures, and about 60% of treatment failures 
were in the average to high functioning groups.
Discussion
Across two independent samples of individuals undergoing treatment for AUD, we find that 
a substantial portion of these individuals (53.14% – 56.76%) are considered treatment 
failures according to the current 4+/5+ heavy drinking cutoff. Amongst these so-called 
treatment failures, we found significant heterogeneity on a variety of psychosocial 
functioning indicators. Specifically, we found three subgroups of individuals in both the 
COMBINE and Project MATCH samples. The smallest class demonstrated the worst 
psychosocial functioning, suggesting that a small minority of these heavy drinkers suffered 
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the brunt of the negative outcomes attributed to treatment failure. Further, a substantial 
number of “failures” exhibited relatively healthy psychosocial functioning including few 
alcohol-related consequences, low mental health symptoms, and high quality of life across 
multiple domains. Indeed, in both samples, the relatively large high-functioning classes of 
treatment “failures” had equal or better psychosocial functioning than the sub-sample of 
treatment “successes” on nearly all outcomes, with the exception of drinking-related 
consequences.
In the research context, our findings question whether the 4+/5+ heavy drinking endpoint is 
sensitive to detecting individuals who are actually at increased risk of impaired functioning, 
or whether some heavy drinkers can still have significant improvements in functioning. 
These results are consistent with recent research showing that some heavy drinking, 
particularly heavy drinking in combination with low risk drinking, is associated with similar 
consequences and health care costs up to 1 and 3 years following treatment as abstinence or 
low risk drinking outcomes (36,37).
The 4+/5+ heavy drinking cutoff is also less relevant or useful in the context of treatment, 
whereby clinicians aim to improve the quality of life and psychosocial functioning of their 
AUD clients. Level of consumption may be a target of many treatments, but more often a 
clinician is interested in clinical benefit, regardless of whether a client is exceeding a 4+/5+ 
heavy drinking cutpoint. In the context of a wide range of harm reduction strategies, 
reducing consumption may be sufficient to reduce harm, but may not always be necessary.
While we do not believe that any consumption-based primary endpoint can reliably delineate 
treatment “successes” from treatment “failures,” we do suggest alternate approaches that 
may move the field forward. One possible approach is to measure outcome in terms of a 
drop in severity of AUD based on DSM-5 (e.g., a drop from AUD – severe to AUD – 
moderate, a drop from moderate to mild, or a drop from mild to “in remission”). In a similar 
vein, and in keeping with how the US FDA measures success with respect to interventions 
for obesity, high blood pressure, and diabetes, outcome could be defined by a clinically 
meaningful reduction in some indicator of symptomatology (e.g., reductions in alcohol-
related problems). In the rare situation that consumption-based cutoffs were deemed 
necessary, we suggest that the only way to derive truly valid cutoffs for individuals would be 
to employ an ecological momentary assessment approach or real time objective alcohol 
monitoring (e.g., transdermal alcohol monitoring, (38)) that can actually map negative 
consequences to specific levels of episodic drinking.
Despite the strengths of using two large datasets with clinical populations, there are a 
number of limitations. First, we used different indicators of psychosocial functioning in our 
LPAs at specific time points and across studies based on availability of the indicators of 
psychosocial functioning and when they were assessed. Another limitation of this study was 
the inability to use the calendar-based data to obtain information regarding the duration of 
drinking episodes. The most recent definition supported by the National Institute on Alcohol 
Abuse and Alcoholism (NIAAA, 2004) defines binge drinking as consuming 4+/5+ drinks 
for women/men within a two-hour period, presumably based on the notion that this leads to 
a blood alcohol level around 0.08 g/dL. Given that we are unable to account for duration of 
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drinking episodes, one could argue that our definition loses some of the sensitivity of a time-
specific measure. Finally, the current study did not examine various time windows (e.g., 30 
days versus 60 days) for evaluating presence or absence of heavy drinking days. Future 
research could consider varying time windows.
Conclusion
Overall, our findings call into question the use of the current 4+/5+ heavy drinking definition 
as it is applied to clinical populations. We believe this application can have negative impacts 
on how researchers and clinicians define treatment success and treatment failure. Any 
alcohol consumption based cutoff will provide a single benchmark for all clients irrespective 
of their baseline use and a host of other factors that may contribute to whether they 
experience the negative consequences and impairments in psychosocial functioning that are 
a hallmark of AUD. Further, these cutoffs fail to account for meaningful improvements made 
by clients who are considered treatment “failures.”
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Depiction of the three latent classes and abstainers/light drinkers sample defined by pattern 
of standardized means on psychosocial variables in COMBINE. SF-12=Short Form Health 
Survey, WHOQOL=World Health Organization Quality of Life Assessment-BREF, 
BSI=Brief Symptom Inventory, DrINC=Drinker Inventory of Consequences. We reversed 
coded the BSI and DrInC variables such that higher scores indicate healthier psychosocial 
functioning (e.g., higher scores indicates lower depressive symptoms). Standardized scores 
were created taking into account abstainers/light drinkers (i.e., whole sample).
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Depiction of the three latent classes and abstainers/light drinkers sample defined by pattern 
of standardized means on psychosocial variables in Project Match. DrINC=Drinker 
Inventory of Consequences, ASI=Addiction Severity Index, BDI=Beck Depression 
Inventory, PFI=Psychosocial Functioning Inventory. We reversed coded the BDI, ASI, and 
DrInC variables such that higher scores indicate healthier psychosocial functioning (e.g., 
higher scores indicates lower depressive symptoms). Standardized scores were created 
taking into account abstainers/light drinkers (i.e., whole sample).
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Table 2















Sample sizes 97 – 100 202 – 206 232 – 236 412 – 415
SF-12 Mental Health −1.767a −0.757b 0.502c 0.136d
SF-12 Physical Health −0.260a 0.178b 0.248b 0.252b
WHOQOL-BREF Physical Health 22.878a 26.677b 30.575c 30.104c
WHOQOL-BREF Psychological Domain 16.700a 20.850b 24.861c 24.127d
WHOQOL-BREF Social Relationships Domain 7.903a 9.766b 11.728c 11.560c
WHOQOL-BREF Environment Domain 24.354a 29.858b 32.658c 32.815c
BSI Depression 73.315a 62.192b 48.754c 51.290d
BSI Anxiety 68.977a 56.034b 45.159c 47.410d
BSI Hostility 63.719a 54.766b 45.071c 46.600c
BSI Interpersonal Sensitivity 68.847a 57.048b 46.422c 49.090d
DrInC Total Consequences 57.149a 34.856b 17.210c 8.570d
Standardized Scores (z−scores)
SF-12 Mental Health −1.507a −0.535b 0.516c 0.329d
SF-12 Physical Health −0.519a −0.008b 0.076b 0.079b
WHOQOL-BREF Physical Health −1.406a −0.287b 0.384c 0.265c
WHOQOL-BREF Psychological Domain −1.533a −0.482b 0.507c 0.319d
WHOQOL-BREF Social Relationships Domain −1.181a −0.425b 0.366c 0.286c
WHOQOL-BREF Environment Domain −1.265a −0.266b 0.268c 0.281c
BSI Depression 1.636a 0.618b −0.604c −0.364d
BSI Anxiety 1.628a 0.453b −0.529c −0.319d
BSI Hostility 1.426a 0.503b −0.485c −0.320c
BSI Interpersonal Sensitivity 1.593a 0.462b −0.562c −0.299d
DrInC Total Consequences 1.577a 0.604b −0.196c −0.575d
Note. SF-12=Short Form Health Survey, WHOQOL-BREF=World Health Organization Quality of Life Assessment-BREF, BSI=Brief Symptom 
Inventory, DrINC=Drinker Inventory of Consequences. Means sharing a subscript in a row indicate means that are not significantly different from 
each other based on Tukey post-hoc comparisons. Standardized scores were created in the full sample.
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Table 3
















DrInC Total Consequences 66.859a 51.151b 21.084c 12.362d
ASI Psychiatric Severity 0.480a 0.216b 0.062c 0.094d
BDI Depression 28.065a 13.755b 4.490c 5.211d
PFI Social Behavior Role 2.527a 3.003b 3.585c 3.536d
PFI Overall Social Role Performance 2.581a 3.350b 4.158c 4.127c
Standardized Scores (z−scores)
DrInC Total Consequences 1.367a 0.751b −0.429c −0.771d
ASI Psychiatric Severity 1.861a 0.456b −0.362c −0.190d
BDI Depression 2.395a 0.692b −0.410c −0.325d
PFI Social Behavior Role −1.7663a −0.793b 0.395c 0.295d
PFI Overall Social Role Performance −1.769a −0.740b 0.339c 0.298c
Note. DrINC=Drinker Inventory of Consequences, ASI=Addiction Severity Index, BDI=Beck Depression Inventory, PFI=Psychosocial Functioning 
Inventory. Means sharing a subscript in a row indicate means that are not significantly different from each other based on Tukey post-hoc 
comparisons. Standardized scores were created in the full sample.
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